Literature DB >> 11275722

Significance of tissue laminin P(1) elastase and fibronectin levels in transitional cell carcinoma of the bladder.

G Kirkali1, E Tüzel, C Güler, S Gezer, Z Kirkali.   

Abstract

OBJECTIVE: Elastase is a serine protease which hydrolyses connective tissue components. Laminin and fibronectin also play an important role in progression and invasion of cancer. The purpose of this study is to investigate the relation between tissue elastase, laminin P(1) and fibronectin levels and tumor characteristics, and analyze the potential of these as prognostic factors in transitional cell carcinoma (TCC) of the bladder.
METHODS: Thirty-four patients with TCC of the bladder and 11 controls were included in this study. Elastase and fibronectin levels in tissue homogenates were determined using an enzyme immunoassay and laminin P(1) by radioimmunoassay. Mean follow-up was 43 months.
RESULTS: The mean elastase level in bladder carcinoma tissue was 120+/-11.42 ng/homogenate protein, while normal tissue level was 12.36+/-2.70 (p<0.01). The carcinoma and normal tissue mean laminin P(1) levels were 7.02+/-0.37 U and 0.65+/-0.10 U/mg homogenate protein, respectively (p<0.01). The mean fibronectin level was 19.97+/-1.45 ng/mg homogenate protein in the carcinoma tissue and 2.16+/-0.40 in normal tissue (p<0.01). There was no correlation between tumor stage, grade, size, multiplicity and elastase, laminin P(1) and fibronectin levels.
CONCLUSION: These results provide evidence that tissue elastase, laminin P(1) and fibronectin levels increase in TCC of the human bladder. Further studies including serum and urine levels should be performed in order to analyze their value as tumor markers in a larger group of patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11275722     DOI: 10.1159/000052456

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  6 in total

1.  Diagnostic value of fibronectin and mutant p53 in the urine of patients with bladder cancer: impact on clinicopathological features and disease recurrence.

Authors:  Sanaa Eissa; Samir F Zohny; Abdel-Rahman N Zekri; Tarek Mostafa El-Zayat; Amany M Maher
Journal:  Med Oncol       Date:  2009-12-11       Impact factor: 3.064

2.  Laminin and transforming growth factor beta-1 in children with vesicoureteric reflux.

Authors:  Anna Sabasiñska; Walentyna Zoch-Zwierz; Anna Wasilewska; Tadeusz Porowski
Journal:  Pediatr Nephrol       Date:  2008-02-21       Impact factor: 3.714

3.  The role of structural extracellular matrix proteins in urothelial bladder cancer (review).

Authors:  Andrea Brunner; Alexandar Tzankov
Journal:  Biomark Insights       Date:  2007-11-05

4.  Evaluation of cellular fibronectin plasma levels as a useful staging tool in different stages of transitional cell carcinoma of the bladder and renal cell carcinoma.

Authors:  A Hegele; R Hofmann; B Kosche; J Kropf
Journal:  Biomark Insights       Date:  2007-02-07

5.  [Transitional cell carcinoma of the bladder. Evaluation of plasma levels of cellular fibronectin as a stage-dependent marker].

Authors:  A Hegele; B Kosche; A J Schrader; S Sevinc; P J Olbert; R Hofmann; J Kropf
Journal:  Urologe A       Date:  2008-09       Impact factor: 0.639

6.  Down-regulation of PKCζ in renal cell carcinoma and its clinicopathological implications.

Authors:  Yeong-Shiau Pu; Chao-Yuan Huang; Jyue-Yu Chen; Wang-Yi Kang; Ying-Chu Lin; Yu-Shiang Shiu; Shu-Ju Chuang; Hong-Jeng Yu; Ming-Kuen Lai; Yu-Chieh Tsai; Wen-Jeng Wu; Tzyh-Chyuan Hour
Journal:  J Biomed Sci       Date:  2012-04-05       Impact factor: 8.410

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.